SUHEUNG CO.,LTD.
KOSPI-listed capsule and health-supplement manufacturer holding about 95% domestic and 8% (3rd globally) hard-capsule market share.
As of 2026-10-11, SUHEUNG CO.,LTD. has 170 Korean MFDS drug approvals, 15 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1973 and listed on KOSPI in 1990, SUHEUNG is a hard-capsule and pharmaceutical/health-supplement contract manufacturer. Its core business is hard-capsule manufacturing, alongside soft-gel pharmaceutical contract manufacturing, health functional foods in soft-capsule, hard-capsule, tablet, liquid/jelly, and powder/granule formats, gelatin and collagen capsule ingredients, and basic-cosmetics OEM/ODM. Its hard-capsule segment holds about 95% domestic market share and ranks 3rd globally with about 8% share.
Products & technology
- Hard capsulesCapsules for pharmaceuticals and health supplements
- Soft capsule contract manufacturingContract manufacturing of soft-gel pharmaceuticals
- Health functional foodsSoft/hard capsules, tablets, liquid/jelly, powder/granule formats
- Gelatin and collagen ingredientsRaw materials for capsules, cosmetics, and health supplements
- Basic cosmetics OEM/ODMContract manufacturing of basic cosmetics including cleansers and body products
Regulatory approvals
data.go.kr170 Korean MFDS drug approvals · 1990–2026
- MFDS drugVita Active Tab.2026-09-03Drug · OTC · Notification202602627
- MFDS drugPoly Top Liquid Soft Capsule2026-07-21Drug · OTC · Notification202602105
- MFDS drugFurito Soft capsule(Cucurbit Semen Oil Extract(15~25->1))2026-07-10Drug · OTC · Notification202602008
- MFDS drugReti Col Max Soft Capsule2026-07-02Drug · OTC · Notification202601927
- MFDS drugPharm Cold Nose Soft Capsule2026-06-26Drug · OTC · Notification202601813
- MFDS drugLead Flu S Soft Capsule2026-06-26Drug · OTC · Notification202601814
- MFDS drugReti Cough Max Soft Capsule2026-06-24Drug · OTC · Notification202601786
- MFDS drugPharm Cold Nose 1 Soft Capsule2026-06-12Drug · OTC · Notification202601670
- MFDS drugPharm Cold Cough Soft Capsule2026-06-11Drug · OTC · Notification202601656
- MFDS drugPharm Cold Soft Capsule2026-06-11Drug · OTC · Notification202601661
- MFDS drugRetico Max Soft Capsule2026-05-26Drug · OTC · Notification202601502
- MFDS drugQTEN Plus Soft Capsule.2026-04-27Drug · OTC · Notification202601239
Show 68 more
- MFDS drugTriple Mag Up Soft Capsule2026-03-31Drug · OTC · Notification202600901
- MFDS drugActive Cold Soft Capsule2026-01-21Drug · OTC · Notification202600184
- MFDS drugHemoen Vita Soft Capsule2026-01-05Drug · OTC · Notification202600027
- MFDS drugReti Col High Soft Capsule2025-11-21Drug · OTC · Notification202503044
- MFDS drugReti Cough High Soft Capsule2025-11-19Drug · OTC · Notification202503012
- MFDS drugPower Reti Cough Soft Capsule2025-11-18Drug · OTC · Notification202502974
- MFDS drugPower Reti Col Soft Capsule2025-11-18Drug · OTC · Notification202502975
- MFDS drugPower Reti Co Soft Capsule2025-11-14Drug · OTC · Notification202502953
- MFDS drugReti Co High Soft Capsule2025-10-29Drug · OTC · Notification202502790
- MFDS drugRona Co Soft Capsule2025-08-21Drug · OTC · Notification202502171
- MFDS drugActive Nose Soft Capsule2025-08-07Drug · OTC · Notification202502059
- MFDS drugDonafen High Soft Capsule2025-07-03Drug · OTC · Notification202501655
- MFDS drugSere Vita soft capsule2025-05-09Drug · OTC · Notification202501137
- MFDS drugMag BB Soft capsule2024-10-31Drug · OTC · Notification202402565
- MFDS drugDonafen A Soft Capsule2024-10-14Drug · OTC · Notification202402426
- MFDS drugEye Chord A Soft Cap2024-09-30Drug · OTC · Notification202402343
- MFDS drugSuheung HPMC Capsule #1SL2024-09-13Drug · OTC · Notification202402243
- MFDS drugMag & B Soft capsule2024-09-05Drug · OTC · Notification202402162
- MFDS drugMag for B Soft Capsule2024-09-02Drug · OTC · Notification202402121
- MFDS drugSuheung EnP Capsule #22024-06-19Drug · OTC · Notification202401471
- MFDS drugEye Chord Soft Cap2024-06-19Drug · OTC · Notification202401474
- MFDS drugRetico Forte Soft Capsule2024-04-30Drug · OTC · Notification202401071
- MFDS drugSCD soft capsule2024-04-16Drug · OTC · Notification202400858
- MFDS drugReticol Puls Soft capsule2024-03-27Drug · OTC · Notification202400670
- MFDS drugPowerssen A Soft Cap.2024-03-08Drug · OTC · Notification202400494
- MFDS drugEigh cough soft capsule2023-11-02Drug · OTC · Notification202303049
- MFDS drugEigh col soft capsule2023-10-25Drug · OTC · Notification202302990
- MFDS drugEigh co soft capsule2023-10-20Drug · OTC · Notification202302953
- MFDS drugechsF soft capsule2022-11-04Drug · OTC · Notification202204005
- MFDS drugDefense Co Soft capsule2022-11-01Drug · OTC · Notification202203959
- MFDS drugDonafen M Soft Capsule2022-04-21Drug · OTC · Notification202201645
- MFDS drugLead Flu Soft Capsule2022-04-19Drug · OTC · Notification202201615
- MFDS drugJanuren Duo Tab. 50/1000mg2022-04-04Drug · Prescription · Approval202201412
- MFDS drugDonaphen f Soft Capsule2022-02-15Drug · OTC · Notification202200707
- MFDS drugDonafen Alpha Soft Capsule2022-02-15Drug · OTC · Notification202200708
- MFDS drugJanuren Tab. 100mg(Sitagliptin phosphate monohydrate)2021-12-09Drug · Prescription · Approval202107871
- MFDS drugMaglezo Soft Capsule2021-12-02Drug · OTC · Notification202107769
- MFDS drugMagrena Soft Capsule2021-12-02Drug · OTC · Notification202107770
- MFDS drugNatcol Soft Capsule2021-11-16Drug · OTC · Notification202107510
- MFDS drugRoaphen-F Soft CapsuleRevoked2021-11-16Drug · OTC · Notification202107499
- MFDS drugMagrion Soft Capsule2021-11-03Drug · OTC · Notification202107304
- MFDS drugMagroan Soft Capsule2021-10-20Drug · OTC · Notification202107040
- MFDS drugMinophen-I Soft CapsuleRevoked2021-10-20Drug · OTC · Notification202107029
- MFDS drugMagrodian Soft Capsule2021-10-19Drug · OTC · Notification202106999
- MFDS drugMagroben Soft Capsule2021-10-19Drug · OTC · Notification202107000
- MFDS drugAmdol Soft CapsuleRevoked2021-10-12Drug · OTC · Notification202106857
- MFDS drugMagromin gold premium Soft Capsule2021-10-08Drug · OTC · Notification202106818
- MFDS drugMagrogi Soft Capsule2021-10-06Drug · OTC · Notification202106751
- MFDS drugMinofen-S Soft Capsule2021-10-05Drug · OTC · Notification202106732
- MFDS drugTopia Tab.(Topiramate)2021-07-07Drug · Prescription · Approval202105130
- MFDS drugEye Nyut Soft CapsuleRevoked2021-07-05Drug · OTC · Notification202105077
- MFDS drugBenamin-F Soft CapsuleRevoked2021-05-14Drug · OTC · Notification202103861
- MFDS drugMinophen Soft CapsuleRevoked2021-05-14Drug · OTC · Notification202103862
- MFDS drugAntinocell Soft CapsuleRevoked2021-04-20Drug · OTC · Notification202103218
- MFDS drugSuheung Tofacitinib Tab. 5mg(tofacitinib aspartate)Revoked2021-03-16Drug · Prescription · Approval202102379
- MFDS drugAlto Miv Tab. 10/10mgRevoked2021-02-18Drug · Prescription · Approval202101593
- MFDS drugAlto Miv Tab. 10/20mgRevoked2021-02-18Drug · Prescription · Approval202101594
- MFDS drugAlto Miv Tab. 10/40mgRevoked2021-02-18Drug · Prescription · Approval202101595
- MFDS drugDonaphen Soft CapsuleRevoked2020-10-28Drug · OTC · Notification202007374
- MFDS drugMomod Tab. 1mg(Finastaride)2020-09-23Drug · Prescription · Approval202006563
- MFDS drugRoaphen Soft CapsuleRevoked2020-09-23Drug · OTC · Notification202006565
- MFDS drugRoaphen-S Soft CapsuleRevoked2020-09-23Drug · OTC · Notification202006566
- MFDS drugBenamin Soft CapsuleRevoked2020-09-23Drug · OTC · Notification202006572
- MFDS drugHemonin F Soft CapsuleRevoked2020-09-16Drug · OTC · Notification202006408
- MFDS drugStiwon Tab. (Artemisia Herb 95% Ethanol Soft Ext.(20→1))Revoked2020-05-14Drug · Prescription · Notification202003473
- MFDS drugMeloxone Capsule 7.5mg(Meloxicam)Revoked2020-04-16Drug · Prescription · Approval202002677
- MFDS drugGabaone Capsule 300mg(Gabapentin)2020-03-25Drug · Prescription · Approval202002076
- MFDS drugGabaone Capsule 100mg(Gabapentin)2020-03-25Drug · Prescription · Approval202002077
Showing the 80 most recent of 170 records.
Clinical trials
data.go.kr2 MFDS clinical trial authorisations · 2015–2016 (Bioequivalence 2)
- Bioequivalence하이콜린정(가칭)2016-04-29
2 trial sites
- Bioequivalence오크린연질캡슐(오메가-3-산 에칠에스텔 90)2015-01-05
2 trial sites
Publications
PubMed · affiliation-matched- Efficacy of a Terminalia chebula-Boswellia serrata Combination in Lipopolysaccharide-Induced Neuroinflammation in Sprague Dawley Rats.
Journal of the American Nutrition Association · 2026-09 · Yadav PK, Kavungala KC, Park GD 외 6
- Efficacy and Safety of Low-Molecular-Weight Collagen Peptide GT for Improving Hair Condition in Individuals with Damaged Hair: A Randomized, Double-Blind, Placebo-Controlled Trial.
International journal of stem cells · 2026-08 · Kim TK, Oh J, Ha YS 외 9
- Low-Molecular-Weight Fish Collagen Peptide Enhances Hair Regrowth via Activation of Proliferative Signaling and Suppression of Inhibitory Pathways.
Marine drugs · 2026-07 · Kim H, Lee Y, Park SH 외 4
- Anti-Obesity Effects of Pear Extract (Pyrus pyrifolia): Clinical Implications and Therapeutic Potential.
International journal of stem cells · 2026-05 · Roh YK, Ha YS, Kim TK 외 7
- A standardized combination of Sphaeranthus indicus and Mangifera indica extracts improves antioxidant defense and anabolic signaling and attenuates dexamethasone-induced skeletal muscle atrophy.
Food & nutrition research · 2026-01 · Kundimi S, Rao T, Park GD 외 4
- SHPro® (mixture of Angelica gigas and Astragalus membranaceus) in men with lower urinary tract symptoms: A randomized, double-blind, placebo-controlled clinical trial.
Investigative and clinical urology · 2025-11 · Lee JH, Yoon D, Park GD 외 5
- Treatment with soybean lecithin-derived α-GPC (SHCog™) improves scopolamine-induced cognitive declines in mice via regulating cholinergic neurotransmission and enhancing neural plasticity in the hippocampus.
Tissue & cell · 2025-04 · Zheng Y, An S, Kim GY 외 4
- Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial.
BMC geriatrics · 2024-09 · Jeon J, Lee SY, Lee S 외 5
- Unripe Pear Extract Suppresses UVB-Induced Skin Photoaging in Hairless Mice and Keratinocytes.
Journal of medicinal food · 2023-12 · Park J, Kim D, Lee M 외 6
- Low-Molecular-Weight Fish Collagen Peptide (Valine-Glycine-Proline-Hydroxyproline-Glycine-Proline-Alanine-Glycine) Prevents Osteoarthritis Symptoms in Chondrocytes and Monoiodoacetate-Injected Rats.
Marine drugs · 2023-11 · Cho W, Park J, Kim J 외 6
Show 5 more publications
- Siraitia grosvenorii Extract Attenuates Airway Inflammation in a Mouse Model of Respiratory Disease Induced by Particulate Matter 10 Plus Diesel Exhaust Particles.
Nutrients · 2023-09 · Sung YY, Kim M, Yuk HJ 외 6
- SH-PRO extract alleviates benign prostatic hyperplasia via ROS-mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo.
Phytotherapy research : PTR · 2023-02 · Park JE, Shin WC, Lee HJ 외 10
- Siraitia grosvenorii Extract Attenuates Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease Induced by Cigarette Smoke and Lipopolysaccharide.
Nutrients · 2023-01 · Kim MS, Kim DS, Yuk HJ 외 6
- Millet seed oil activates β-catenin signaling and promotes hair growth.
Frontiers in pharmacology · 2023-01 · Lee E, Seo HD, Kim D 외 7
- Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease.
Journal of medicinal food · 2021-10 · Lee M, Kim D, Park SJ 외 4
Patents
KIPRIS · applicant-matchedPCT · Published · 2025-02 · Application PCT/KR2025/002364
Published · 2025-02 · Application 1020250020825
Published · 2024-08 · Application 1020240114878
Published · 2024-08 · Application 1020240102731
Registered · 2024-04 · Application 1020240045721
Registered · 2024-04 · Application 1020240045716
CN · Published · 2024-01 · Application 202410079307.9
US · Published · 2023-12 · Application 18399206
EP · Published · 2023-12 · Application 23220535.1
Rejected · 2023-12 · Application 1020230192879
Show 93 more patents
Rejected · 2023-06 · Application 1020230081773
US · Published · 2023-05 · Application 18326585
CN · Published · 2023-05 · Application 202310594500.1
EP · Published · 2023-05 · Application 23174214.9
Registered · 2023-02 · Application 1020230018468
Registered · 2022-10 · Application 1020220127275
Registered · 2022-09 · Application 1020220110455
PCT · Published · 2022-08 · Application PCT/KR2022/012706
Registered · 2022-07 · Application 1020220084323
Registered · 2022-06 · Application 1020220068153
Registered · 2021-02 · Application 1020210014885
Rejected · 2021-01 · Application 1020210009045
Rejected · 2020-12 · Application 1020200180577
Rejected · 2020-12 · Application 1020200180574
Rejected · 2020-06 · Application 1020200066185
Registered · 2020-05 · Application 1020200062871
CN · Published · 2020-02 · Application 202010100932.9
US · Registered · 2020-02 · Application 16793179
EP · Registered · 2020-02 · Application 20156545.4
Registered · 2020-01 · Application 1020200000588
- MANUFACTURING METHOD FOR SOFTGEL CAPSULE CONTAINING SOLID AND LIQUID FORMULATIONS AS CORE INGREDIENT
US · Published · 2019-08 · Application 16557068
Registered · 2019-04 · Application 1020190050212
Registered · 2019-02 · Application 1020190019076
Registered · 2018-11 · Application 1020180136325
Registered · 2018-09 · Application 1020180115729
Registered · 2018-04 · Application 1020180048211
Rejected · 2018-04 · Application 1020180048351
CN · Published · 2018-03 · Application 201810293032.3
US · Registered · 2018-03 · Application 15941924
EP · Registered · 2018-03 · Application 18163408.0
CN · Published · 2018-01 · Application 201810088891.9
US · Registered · 2018-01 · Application 15880995
EP · Registered · 2018-01 · Application 18153754.9
Registered · 2018-01 · Application 1020180006905
Registered · 2017-11 · Application 1020170147289
- Manufacturing method for softgel capsule containing solid and liquid formulations as core ingredient
CN · Published · 2015-10 · Application 201510648481.1
- MANUFACTURING METHOD FOR SOFTGEL CAPSULE CONTAINING SOLID AND LIQUID FORMULATIONS AS CORE INGREDIENT
EP · Published · 2015-10 · Application 15188232.1
- MANUFACTURING METHOD FOR SOFTGEL CAPSULE CONTAINING SOLID AND LIQUID FORMULATIONS AS CORE INGREDIENT
US · Published · 2015-09 · Application 14865194
Registered · 2015-08 · Application 1020150117684
Registered · 2015-08 · Application 1020150117683
Registered · 2015-08 · Application 1020150117682
Expired · 2015-06 · Application 1020150084745
Registered · 2014-12 · Application 1020140177223
Rejected · 2013-12 · Application 1020130149776
Registered · 2013-12 · Application 1020130148952
Registered · 2013-07 · Application 1020130086882
Registered · 2012-06 · Application 1020120070743
Expired · 2012-06 · Application 1020120071153
Registered · 2012-05 · Application 1020120052807
EP · Registered · 2012-04 · Application 12774763.2
Registered · 2012-03 · Application 1020120026920
Expired · 2012-03 · Application 1020120026919
Registered · 2011-04 · Application 1020110036823
Rejected · 2008-05 · Application 1020080042696
Rejected · 2008-05 · Application 1020080042700
Expired · 2005-07 · Application 1020050060982
Expired · 2005-05 · Application 1020050037329
Expired · 2005-03 · Application 1020050025298
Expired · 2005-02 · Application 1020050014138
Expired · 2004-02 · Application 1020040007174
Expired · 2003-09 · Application 1020030067241
Expired · 2002-10 · Application 1020020065793
Expired · 2002-07 · Application 1020020041890
Expired · 2002-07 · Application 1020020040624
Expired · 2000-11 · Application 1020000071155
Expired · 2000-03 · Application 1020000010990
Expired · 1999-07 · Application 1019990027950
Rejected · 1999-05 · Application 1019990018419
Expired · 1998-12 · Application 1019980053215
Expired · 1998-11 · Application 1019980048983
Rejected · 1998-11 · Application 1019980047920
Expired · 1998-07 · Application 2019980012236
Rejected · 1997-09 · Application 1019970045758
Rejected · 1997-07 · Application 1019970034217
Rejected · 1996-08 · Application 1019960033835
Expired · 1996-06 · Application 1019960019582
Rejected · 1996-04 · Application 2019960007819
Expired · 1996-04 · Application 1019960010937
Expired · 1996-01 · Application 1019960000385
Expired · 1995-09 · Application 2019950026161
Rejected · 1995-08 · Application 1019950025094
Rejected · 1993-10 · Application 1019930021649
Expired · 1993-10 · Application 1019930021650
Expired · 1993-09 · Application 1019930018115
Expired · 1993-09 · Application 1019930018116
Rejected · 1993-09 · Application 1019930018114
Expired · 1993-09 · Application 1019930018112
Expired · 1993-09 · Application 1019930018113
Expired · 1990-10 · Application 2019900015689
Rejected · 1989-11 · Application 2019890017332
Rejected · 1988-02 · Application 2019880002261
Expired · 1986-12 · Application 2019860020833
- Subsidiary: (주)한국코스모보관및사용이간편한재털이
Abandoned · 1985-02 · Application 2019850001869
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive2
- OpenAIOAI-SearchBot71
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for SUHEUNG CO.,LTD. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryBiotech & Drug Discovery
KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.
Drug delivery system company behind the long-acting injectable platform IVL-DrugFluidic and the LNP delivery platform IVL-GeneFluidic.
Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.
A holding company overseeing 54 affiliates including its main biopharmaceutical subsidiary GC, with no direct product manufacturing of its own.
Founded in 2015 and listed on KOSPI in 2021, Prestige BioPharma develops antibody biosimilars and novel antibody drugs including Tuznue.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.
A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition